Financials

  • Market Capitalization 16.52 M
  • Employee 14
  • Founded 2017
  • CEO N/A
  • Website www.werewolftx.com
  • Headquarter Delaware, United States
  • FIGI BBG00QXQ9XK4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.48
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4659
KALA
KALA BIO, Inc. - Common Stock
0.96 USD-11.93%-36.42%-64.18%-82.70%17.85 M USD
4677
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.83 USD-1.29%+15.02%+21.59%+20.44%16.59 M USD
4689
KTTA
Pasithea Therapeutics Corp. - Common Stock
0.48 USD-2.04%-7.69%-11.11%-27.27%16.04 M USD
4694
QNCX
Quince Therapeutics, Inc. - Common Stock
19.29 USD+11.83%+8.74%+1996.74%+1015.03%15.72 M USD

Noticias